What is HOPE?
![](/images/librariesprovider63/default-album/hope-horizontal-logo.jpg?sfvrsn=c444d871_1)
- First nationwide large-scale pragmatic four-arm (1:1:1:1) parallel cluster randomised control trial with General Practitioners in Singapore
- Study aim: To evaluate the effectiveness of three combinations of interventions in reducing the risk of cardiovascular disease (CVD) of individuals at risk of CVD in the primary care setting in Singapore
- Study duration: 6 months per participant
- Target number of participants: 1,500
- For information on the research study, click here